Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,755 | -30,704 | -22,639 | -14,897 | -7,517 |
| Depreciation Amortization | 222 | 660 | 502 | 334 | 165 |
| Income taxes - deferred | -37 | N/A | N/A | N/A | N/A |
| Accounts receivable | 40 | -232 | 77 | 5 | 11 |
| Other Working Capital | -1,181 | 556 | 191 | 1,044 | 740 |
| Other Operating Activity | -3,508 | 994 | -19 | 252 | 141 |
| Operating Cash Flow | $-8,219 | $-28,726 | $-21,888 | $-13,262 | $-6,460 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,158 | 24,609 | 18,743 | 18,818 | 9,384 |
| PPE Investments | -181 | -315 | -252 | -238 | -137 |
| Investing Cash Flow | $4,977 | $24,294 | $18,491 | $18,580 | $9,247 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 6,893 | N/A | N/A | N/A |
| Common Stock Issued | 119 | 177 | 177 | 177 | 174 |
| Financing Cash Flow | $119 | $7,070 | $177 | $177 | $174 |
| Exchange Rate Effect | -163 | 753 | 813 | 500 | 104 |
| Beginning Cash Position | 20,486 | 17,095 | 17,095 | 17,095 | 17,095 |
| End Cash Position | 17,200 | 20,486 | 14,688 | 23,090 | 20,160 |
| Net Cash Flow | $-3,286 | $3,391 | $-2,407 | $5,995 | $3,065 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,219 | -28,726 | -21,888 | -13,262 | -6,460 |
| Capital Expenditure | -181 | -315 | -252 | -238 | -137 |
| Free Cash Flow | -8,400 | -29,041 | -22,140 | -13,500 | -6,597 |